FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1292-1293 April 22, 1999 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Terbinafine is an antifungal agent that is widely prescribed for common skin infections.¹ We describe a patient who had taken terbinafine and in whom fulminant hepatic failure developed, requiring orthotopic liver transplantation.

A 48-year-old woman took 250 mg of terbinafine daily for five days for a fungal nail infection. Over the next four weeks, fulminant hepatic failure developed. The patient had been taking dothiepin (75 mg per day), which is a tricyclic antidepressant, and propranolol (40 mg twice daily) for more than 18 months. She had no risk factors for liver disease, a minimal intake of alcohol . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Andrade, R. J., Lucena, M. I., Berger, C., Johnstone, D., Fleckman, P. (2002). Acute Fulminant Hepatitis After Treatment With Rabeprazole and Terbinafine: Is Rabeprazole the Culprit?. Arch Intern Med 162: 360-361 [Full Text]  
• Johnstone, D., Berger, C., Fleckman, P. (2001). Acute Fulminant Hepatitis After Treatment With Rabeprazole and Terbinafine. Arch Intern Med 161: 1677-1678 [Full Text]